Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Contract research news in brief

December 8, 2010 Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations

Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …
News

Trial hitch for Pfizer’s leukaemia drug submission plans

December 7, 2010 Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia

Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …
News

Roche’s MabThera successor shows phase II promise

December 6, 2010 Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia

The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
News

Surprise exit for Pfizer chief executive Jeffrey Kindler

December 6, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession

Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
News

Apitope appoints Hayley French

December 6, 2010 Research and Development, Sales and Marketing Apitope, Hayley French, appointment, research and development, sales and marketing

Belgium-based biopharmaceutical company Apitope has appointed Hayley French to its management team as commercial director. She will be responsible for …
Appointment

Caligor Rx strengthens its European Team

December 3, 2010 Research and Development Caligor Rx, Jacquelyn May, Jess McKenna, appointment, research and development

Clinical trial procurement firm Caligor Rx has appointed Jess McKenna head of quality assurance and customer relationships and Jacquelyn May …
Appointment

Merck acquires innovative insulin firm SmartCells

December 3, 2010 Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin

Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …
News

Tolerx to collaborate on first-in-class cancer antibody

December 2, 2010 Research and Development Cancer, T cell, Torelx, monoclonal antibody

US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
News

EMA to widen public access to documents

December 1, 2010 Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency

The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …
News

New chief executive for Merck & Co

December 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough

Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
News

Dr Martino Picardo to lead Stevenage Bioscience Catalyst

December 1, 2010 Research and Development Dr Martino Pacardo, Stevenage Bioscience Catalyst, appointment, research and development

New UK science park Stevenage Bioscience Catalyst (SBC) has appointed Dr Martino Picardo as its first chief executive. Dr Picardo …
Appointment

UK pharma welcomes government reforms

November 30, 2010 Manufacturing and Production, Research and Development, Sales and Marketing ABHI, ABPI, BIA, R&D tax credits, UK pharma, patent box

The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …
News

Penn Pharma appoints new chief executive

November 30, 2010 Manufacturing and Production, Research and Development David Cooper, Penn Pharma, Richard Yarwood, appointment, manufacturing and production, research and development

Richard Yarwood has joined pharmaceutical services provider Penn Pharma as chief executive. He has more than 33 years experience in …
Appointment

Pharma unprepared for personalised oncology

November 29, 2010 Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine

The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …
News

Pharma outsourcing recovering, but tough times are ahead

November 26, 2010 Manufacturing and Production, Research and Development AAPS, American Association of Pharmaceutical Sciences, Jim Miller, Pharmsource, contract manufacturing, contract research, pharma outsourcing

There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026